Papillomavirus Infections

The proximate cause is infection with papillomaviruses, especially human papillomavirus (HPV). Disease patterns vary by HPV genotype and by the anatomical site involved, and HPV-16 is specifically highlighted in pharyngeal disease. Persistent HPV infection is also described as a driver of HPV-related cervical cancer.

Papillomavirus disease reflects viral infection of epithelial tissues with outcomes ranging from subclinical infection and latency to productive infection, benign lesions, and malignant progression. The literature emphasizes host immune surveillance, viral immune evasion, and persistent infection as central to disease maintenance and progression. In cancer-associated disease, the tumor microenvironment and transcriptomic changes are implicated in progression and therapeutic response.

Risk varies with HPV genotype, regional conditions, the study population, and the anatomical site sampled. HPV-related diseases are reported as more prevalent in developing countries. For head and neck disease, tobacco consumption and alcohol abuse are associated with oral cavity and larynx cancers, while pharyngeal cancers are increasingly attributed to HPV infection.

Management is described at the level of prevention, screening, and treatment of HPV-related lesions and cancers. The literature supports HPV nucleic acid testing and cytology for screening, with newer approaches including DNA methylation triage, HPV integration detection, liquid biopsies, and AI-assisted diagnostics. Therapeutic strategies include surgery and radiotherapy for head and neck squamous cell carcinoma, and immune checkpoint inhibition such as pembrolizumab in PD-L1-positive recurrent or metastatic cervical cancer; prevention and control also include efforts to eradicate HPV and reverse precancerous lesions.